genprowebdirectory
Facebook
Linkedin
RSS
Twitter
Youtube
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Search
Facebook
Linkedin
RSS
Twitter
Youtube
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Home
2010
Ligand Pharmaceuticals
Industry News
Trevena Raises $35M to Fund Phase II Trial with Heart Failure Drug
News
Ligand Pays $2.75M for Certain Rights to AstraZeneca’s Mid-Stage Asthma Program
News
GSK Wins EC Clearance for Drug to Treat Idiopathic Thrombocytopenic Purpura
News
Pfizer Pays $3.1M to Re-Up Agreement with Ligand for an Additional Year
Industry News
Ligand to Acquire Neurogen for $11M in Stock Plus Contingent Value Rights
Insights
Streamlining In Silico Compound Profiling
News
Ligand Earns $1M Milestone from Schering-Plough
News
Trevena to Use Ligand’s Library to Identify GPCR Therapeutics
News
GSK Gains Rights to Ligand’s Thrombopoietin Program with an Initial Payment of $5M
News
Ligand Inks Stock-for-Stock Purchase Deal with Pharmacopeia Worth $55M
1
2
3
4
Page 3 of 4
Scroll Up